Journal
JOURNAL OF ENVIRONMENTAL CHEMICAL ENGINEERING
Volume 9, Issue 5, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.jece.2021.105864
Keywords
FeVO4; Nanorods; Peroxymonosulfate; Oxytetracycline; Activation
Categories
Funding
- Fundamental Research Funds for the Central Universities, China [N2003016]
- Shenyang Science and Technology Bureau, China [RC180291]
Ask authors/readers for more resources
FeVO4 nanorods were successfully synthesized and employed as PMS activators for efficient degradation of oxytetracycline (OTC). The FeVO4 nanorods exhibited excellent catalytic performance and stability, showing significant degradation efficiency towards OTC. This study provides a new environmentally friendly, low-cost, efficient, and stable PMS activator for the removal of antibiotics.
In this work, FeVO4 nanomds were successfully synthesized and employed as peroxymonosulfate (PMS) activators for oxytetracycline (OTC) degradation. The obtained FeVO4 nanorods exhibited excellent catalytic performance for PMS activation because of the synchronous transformations of Fe3+/Fe2+, V5+/V4+ and Fe3+/V4+, and abundant adsorbed oxygen (O-ads). Almost 100% of OTC can be decomposed via FeVO4 activating PMS in 40 min and the reaction rate constant (k) was 0.1073 min(-1), being 5.65 times of commercial Co3O4 (0.0219 min(-1)). Meanwhile, FeVO4 exhibited a good stability and reusability. In addition, the impacts of experimental parameters (catalysts and PMS dosage, temperature, pH, and co-existing anions) on OTC degradation were detected in detail. It was proved that center dot O-2(-),center dot OH and O-1(2) were generated and the contribution role in OTC degradation followed the sequence center dot OH > O-1(2) approximate to O-2(-). The possible mechanism of PMS activation by FeVO4 was deeply explored and the OTC degradation pathway was deduced according to the detected degradation intermediates. This study develops one new environmental-friendly, low cost, high efficiency and stable PMS activator for the efficient removal of antibiotics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available